EUVIMEDEUVIMED entdecken
Crossref

SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes

Uma D. Alappan, Ashwin K. Chetty, Warren Carter, Nicholas Wells, Dana Alameddine, Silvio Inzucchi, Raul J. Guzman, Cassius Iyad Ochoa Chaar

Journal of Vascular Surgery · 2025-06 · 81 (6) · e140-e142

DOI: 10.1016/j.jvs.2025.03.279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2025-06. Verfasst von Uma D. Alappan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Alappan, U. D., Chetty, A. K., Carter, W., Wells, N., Alameddine, D., Inzucchi, S., Guzman, R. J., & Chaar, C. I. O. (2025). SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes. Journal of Vascular Surgery, 81(6), e140-e142. https://doi.org/10.1016/j.jvs.2025.03.279

Vancouver

Alappan UD, Chetty AK, Carter W, Wells N, Alameddine D, Inzucchi S, et al. SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes. Journal of Vascular Surgery. 2025;81(6):e140-e142. doi:10.1016/j.jvs.2025.03.279

BibTeX
@article{Alappan2025,
  author = {Alappan, Uma D. and Chetty, Ashwin K. and Carter, Warren and Wells, Nicholas and Alameddine, Dana and Inzucchi, Silvio and Guzman, Raul J. and Chaar, Cassius Iyad Ochoa},
  title = {SGLT2 Inhibitors are not Associated With Amputation After Lower Extremity Revascularization in Patients With Diabetes},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  volume = {81},
  number = {6},
  pages = {e140--e142},
  doi = {10.1016/j.jvs.2025.03.279}
}
Kostenlos starten →